Ro 24-7429 Uses, Dosage, Side Effects and more
Ro 24-7429 is under investigation in clinical trial NCT00002314 (A Study of Ro 24-7429 in Patients With Hiv-related Kaposi's Sarcoma).
| Trade Name | Ro 24-7429 |
| Generic | Ro 24-7429 |
| Type | |
| Formula | C14H13ClN4 |
| Weight | Average: 272.74 Monoisotopic: 272.0828741 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
